---
created: 2025-04-13
updated: 2025-04-13T10:53
id: tEnrU[N*7J
specialty: pharmaco
specialty_id: 335
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::11-antitumor-antibiotics
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::11-antitumor-antibiotics::anthracyclines
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::doxorubicin,-daunorubicin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::02-dna-&-cellular-division::03-bleomycin,-doxorubicin,-daunorubicin,-actinomycin-d::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::15000-15999::15027
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::4-loweryield"
type: flashcard
---

# Question
Doxorubicin can cause a(n) **neutropenic** enterocolitis, a life-threatening acute transmural inflammation of the **cecum**

---

# Answer
This is also known as Typhlitis      in the picture, marked asymmetric cecal wall thickening observed - The ascending colon and ileum are typically involved too - This is typically due to neutropenia (induced by doxorubicin / taxols) resulting in infection of the ileum by gram + enteric commensals of the gut (most commonly Clostridium Septicum)